Aurora Cannabis (ACB) Gains from Equity Investments (2017 - 2025)

Aurora Cannabis (ACB) has reported Gains from Equity Investments for 9 consecutive years, with $33.1 million the latest figure, recorded in Q4 2025.

• Quarterly Gains from Equity Investments rose 6.75% year-over-year to $33.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $116.0 million (up 21.16% YoY) and the FY2023 annual result came in at $10.9 million, up 59.41% from the prior year.
• Gains from Equity Investments rose to $33.1 million in Q4 2025 per ACB's latest filing, from $25.9 million in the prior quarter.
• Over the last five years, Gains from Equity Investments for ACB reached as high as $33.1 million in Q4 2025 and fell as low as -$57.2 million in Q1 2021.
• A 5-year average of $10.6 million and a median of $15.1 million in 2023 frame the typical range for Gains from Equity Investments.
• Annual changes were most pronounced in 2021 — Gains from Equity Investments tumbled 340.45% — and 2022, when it soared 190.29%.
• Year by year, Gains from Equity Investments stood at -$8.8 million in 2021, then soared by 190.29% to $7.9 million in 2022, then soared by 90.73% to $15.1 million in 2023, then jumped by 105.12% to $31.0 million in 2024, then grew by 6.75% to $33.1 million in 2025.
• According to Business Quant data, Gains from Equity Investments over the past three periods registered $33.1 million, $25.9 million, and $26.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.